Abstract
In the 70s, the amino acid taurine was found essential for photoreceptor survival. Recently, we found that taurine depletion can also trigger retinal ganglion cell degeneration both in vitro and in vivo. Therefore, evaluation of taurine levels could be a crucial biomarker for different pathologies of retinal ganglion cells such as glaucoma. Because different breeds of dog can develop glaucoma, we performed taurine measurements on plasma and aqueous humour samples from pet dogs. Here, we exposed results from a pilot study on normal selected breed of pet dogs, without any ocular pathology. Samples were collected by veterinarians who belong to the Réseau Européen d’Ophtalmologie Vétérinaire et de Vision Animale. Following measurements by high-performance liquid chromatography (HPLC), the averaged taurine concentration was 162.3 μM in the plasma and 51.8 μM in the aqueous humour. No correlation was observed between these two taurine concentrations, which exhibited a ratio close to 3. Further studies will determine if these taurine concentrations are changed in glaucomatous dogs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- RGC:
-
Retinal ganglion cells
- HPLC:
-
High-performance liquid chromatography
References
Alroy J, Rush JE, Sarkar S (2005) Infantile dilated cardiomyopathy in Portuguese water dogs: correlation of the autosomal recessive trait with low plasma taurine at infancy. Amino Acids 28:51–56
Brons C, Spohr C, Storgaard H, Dyerberg J, Vaag A (2004) Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. Eur J Clin Nutr 58:1239–1247
Buncic JR, Westall CA, Panton CM, Munn JR, MacKeen LD, Logan WJ (2004) Characteristic retinal atrophy with secondary “inverse” optic atrophy identifies vigabatrin toxicity in children. Ophthalmology 111:1935–1942
Duboc A, Hanoteau N, Simonutti M, Rudolf G, Nehlig A, Sahel JA, Picaud S (2004) Vigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in rats. Ann Neurol 55:695–705
Durelli L, Mutani R (1983) The current status of taurine in epilepsy. Clin Neuropharmacol 6:37–48
Earle KE, Smith PM (1992) The effect of dietary supplementation with cysteic acid on the plasma taurine concentration of cats maintained on a taurine-restricted diet. Adv Exp Med Biol 315:23–32
Frisen L, Malmgren K (2003) Characterization of vigabatrin-associated optic atrophy. Acta Ophthalmol Scand 81:466–473
Froger N, Cadetti L, Lorach H, Martins J, Bemelmans AP, Dubus E et al (2012) Taurine Provides Neuroprotection against Retinal Ganglion Cell Degeneration. PLoS One 7(10):e42017
Gaucher D, Arnault E, Husson Z, Froger N, Dubus E, Gondouin P, Dherbecourt D, Degardin J, Simonutti M, Fouquet S, Benahmed MA, Elbayed K, Namer IJ, Massin P, Sahel JA, Picaud S (2012) Taurine deficiency damages retinal neurones: cone photoreceptors and retinal ganglion cells. Amino Acids 43:1979–1993
Hayes KC, Carey RE, Schmidt SY (1975) Retinal degeneration associated with taurine deficiency in the cat. Science 188:949–951
Heller-Stilb B, van Roeyen C, Rascher K, Hartwig HG, Huth A, Seeliger MW, Warskulat U, Haussinger D (2002) Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J 16:231–233
Hillenkamp J, Hussain AA, Jackson TL, Constable PA, Cunningham JR, Marshall J (2004) Compartmental analysis of taurine transport to the outer retina in the bovine eye. Invest Ophthalmol Vis Sci 45:4099–4105
Huxtable RJ (1989) Taurine in the central nervous system and the mammalian actions of taurine. Prog Neurobiol 32:471–533
Jammoul F, Degardin J, Pain D, Gondouin P, Simonutti M, Dubus E, Caplette R, Fouquet S, Craft CM, Sahel JA, Picaud S (2010) Taurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treated neonatal rats. Mol Cell Neurosci 43:414–421
Jammoul F, Wang Q, Nabbout R, Coriat C, Duboc A, Simonutti M, Dubus E, Craft CM, Ye W, Collins SD, Dulac O, Chiron C, Sahel JA, Picaud S (2009) Taurine deficiency is a cause of vigabatrin-induced retinal phototoxicity. Ann Neurol 65:98–107
Le Meur G, Stieger K, Smith AJ, Weber M, Deschamps JY, Nivard D, Mendes-Madeira A, Provost N, Pereon Y, Cherel Y, Ali RR, Hamel C, Moullier P, Rolling F (2007) Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium. Gene Ther 14:292–303
Madl JE, McIlnay TR, Powell CC, Gionfriddo JR (2005) Depletion of taurine and glutamate from damaged photoreceptors in the retinas of dogs with primary glaucoma. Am J Vet Res 66:791–799
Pasantes-Morales H, Quiroz H, Quesada O (2002) Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year follow-up study. Metab Brain Dis 17:183–197
Pasantes-Morales H, Quesada O, Carabez A, Huxtable RJ (1983) Effects of the taurine transport antagonist, guanidinoethane sulfonate, and beta-alanine on the morphology of rat retina. J Neurosci Res 9:135–143
Rascher K, Servos G, Berthold G, Hartwig HG, Warskulat U, Heller-Stilb B, Haussinger D (2004) Light deprivation slows but does not prevent the loss of photoreceptors in taurine transporter knockout mice. Vision Res 44:2091–2100
Ravindran J, Blumbergs P, Crompton J, Pietris G, Waddy H (2001) Visual field loss associated with vigabatrin: pathological correlations. J Neurol Neurosurg Psychiatry 70:787–789
Rosolen SG, Saint-MacAry G, Gautier V, Legargasson JF (2001) Ocular fundus images with confocal scanning laser ophthalmoscopy in the dog, monkey and minipig. Vet Ophthalmol 4:41–45
Rosolen SG, Riviere ML, Lavillegrand S, Gautier B, Picaud S, Legargasson JF (2012) Use of a combined slit-lamp SD-OCT to obtain anterior and posterior segment images in selected animal species. Vet Ophthalmol 15 (suppl.2):105–115
Schmidt SY, Aguirre GD (1985) Reductions in taurine secondary to photoreceptor loss in Irish setters with rod-cone dysplasia. Invest Ophthalmol Vis Sci 26:679–683
Shao A, Hathcock JN (2008) Risk assessment for the amino acids taurine, L-glutamine and L-arginine. Regul Toxicol Pharmacol 50:376–399
Tao W, Wen R, Goddard MB, Sherman SD, O’Rourke PJ, Stabila PF, Bell WJ, Dean BJ, Kauper KA, Budz VA, Tsiaras WG, Acland GM, Pearce-Kelling S, Laties AM, Aguirre GD (2002) Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci 43:3292–3298
Wild JM, Robson CR, Jones AL, Cunliffe IA, Smith PE (2006) Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer. Invest Ophthalmol Vis Sci 47:917–924
Yamori Y, Liu L, Mori M, Sagara M, Murakami S, Nara Y, Mizushima S (2009) Taurine as the nutritional factor for the longevity of the Japanese revealed by a world-wide epidemiological survey. Adv Exp Med Biol 643:13–25
Acknowledgments
Authors acknowledge Dr. Azoulay, T.; Dr. Boderiou, Y.; Boillot, T.; Cantaloube, B.; Durieux, P.; Goulle, F.; Isard, P-F.; Maller, D.; Michaud, Y.; Philippe, R.; and Rosolen, SG. from the REOVVA group (www.reovva.com) for their contribution to this work. This work was supported by INSERM, Université Pierre et Marie Curie (Paris VI), Fondation Ophtalmologique A. de Rothschild (Paris), Fédération de la Recherche Médicale and Fondation Bailly, the city of Paris and the Regional Council of Ile-de-France.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this paper
Cite this paper
Rosolen, SG., Neveux, N., Sahel, JA., Picaud, S., Froger, N. (2013). Evaluation of the Taurine Concentrations in Dog Plasma and Aqueous Humour: A Pilot Study. In: El Idrissi, A., L'Amoreaux, W. (eds) Taurine 8. Advances in Experimental Medicine and Biology, vol 775. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6130-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6130-2_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6129-6
Online ISBN: 978-1-4614-6130-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)